US FDA issues guidance on pre-clinical testing of heart valves
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration has issued draft guidance to help heart valve manufacturers prepare applications for investigational device exemptions (that allow the device to be used in a clinical study) and pre-market approval of their products1,2.